Heparin Immobilized Porous PLGA Microspheres for Angiogenic Growth Factor Delivery
- 1.8k Downloads
Heparin immobilized porous poly(d,l-lactic-co-glycolic acid) (PLGA) microspheres were prepared for sustained release of basic fibroblast growth factor (bFGF) to induce angiogenesis.
Materials and Methods
Porous PLGA microspheres having primary amine groups on the surface were prepared using an oil-in-water (O/W) single emulsion method using Pluronic F-127 as an extractable porogen. Heparin was surface immobilized via covalent conjugation. bFGF was loaded into the heparin functionalized (PLGA-heparin) microspheres by a simple dipping method. The bFGF loaded PLGA-heparin microspheres were tested for in vitro release and in vivo angiogenic activity.
PLGA microspheres with an open-porous structure were formed. The amount of conjugated amine group onto the microspheres was 1.93 ± 0.01 nmol/mg-microspheres, while the amount of heparin was 95.8 pmol/mg-microspheres. PLGA-heparin microspheres released out bFGF in a more sustained manner with a smaller extent of initial burst than PLGA microspheres, indicating that surface immobilized heparin controlled the release rate of bFGF. Subcutaneous implantation of bFGF loaded PLGA-heparin microspheres in mice significantly induced the formation of new vascular microvessels.
PLGA microspheres with an open porous structure allowed significant amount of heparin immobilization and bFGF loading. bFGF loaded PLGA-HP microspheres showed sustained release profiles of bFGF in vitro, demonstrating reversible and specific binding of bFGF to immobilized heparin. They also induced local angiogenesis in vivo in an animal model.
Key wordsangiogenesis growth factor delivery heparin PLGA porous microsphere
This research was supported by grants from the Ministry of Commerce, Industry and Energy (10011366) and from the Ministry of Science and Technology, National Research Laboratory Program, Republic of Korea.
- 6.H. Lee, R. A. Cusick, F. Browne, T. H. Kim, P. X. Ma, H. Utsunomiya, R. Langer, and J. Vacanti. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation 73:1589–1593 (2002).PubMedCrossRefGoogle Scholar
- 10.J. L. Cleland, E. T. Duenas, A. Park, A. Daugherty, J. Kahn, and J. Kowalski. Development of poly-(d,l-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control. Release 72:13–24 (2001).PubMedCrossRefGoogle Scholar
- 19.G. T. Hermanson. Bioconjugate Techniques, Academic, San Diego, California, 1996.Google Scholar
- 30.M. Fugita, M. Ishihara, M. Simizu, K. Obara, T. Ishizuka, Y. Saito, H. Yura, Y. Morimoto, B. Takase, T. Matsui, M. Kikuchi, and T. Maehara. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25:699–706 (2004).CrossRefGoogle Scholar